Ojha Pooja, Anderson Benjamin J, Draper Evan W, Flaker Susan M, Siska Mark H, Mara Kristin C, Kennedy Brian D, Schreier Diana J
Department of Pharmacy Services, Mayo Clinic, Rochester, MN 55905, United States.
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, United States.
JAMIA Open. 2024 Jan 27;7(1):ooae003. doi: 10.1093/jamiaopen/ooae003. eCollection 2024 Apr.
Since the 1970s, a plethora of tools have been introduced to support the medication use process. However, automation initiatives to assist pharmacists in prospectively reviewing medication orders are lacking. The review of many medications may be protocolized and implemented in an algorithmic fashion utilizing discrete data from the electronic health record (EHR). This research serves as a proof of concept to evaluate the capability and effectiveness of an electronic prospective medication order review (EPMOR) system compared to pharmacists' review.
A subset of the most frequently verified medication orders were identified for inclusion. A team of clinical pharmacist experts developed best-practice EPMOR criteria. The established criteria were incorporated into conditional logic built within the EHR. Verification outcomes from the pharmacist (human) and EPMOR (automation) were compared.
Overall, 13 404 medication orders were included. Of those orders, 13 133 passed pharmacist review, 7388 of which passed EPMOR. A total of 271 medication orders failed pharmacist review due to order modification or discontinuation, 105 of which passed EPMOR. Of the 105 orders, 19 were duplicate orders correctly caught by both EPMOR and pharmacists, but the opposite duplicate order was rejected, 51 orders failed due to scheduling changes.
This simulation was capable of effectively discriminating and triaging orders. Protocolization and automation of the prospective medication order review process in the EHR appear possible using clinically driven algorithms.
Further research is necessary to refine such algorithms to maximize value, improve efficiency, and minimize safety risks in preparation for the implementation of fully automated systems.
自20世纪70年代以来,已引入大量工具来支持药物使用过程。然而,缺乏协助药剂师前瞻性审查用药医嘱的自动化举措。许多药物的审查可以通过利用电子健康记录(EHR)中的离散数据,以算法方式进行规范化并实施。本研究作为一项概念验证,旨在评估电子前瞻性用药医嘱审查(EPMOR)系统与药剂师审查相比的能力和有效性。
确定纳入最常被核实的用药医嘱子集。一组临床药剂师专家制定了最佳实践EPMOR标准。既定标准被纳入EHR中构建的条件逻辑。比较了药剂师(人工)和EPMOR(自动化)的核实结果。
总体而言,共纳入13404条用药医嘱。在这些医嘱中,13133条通过药剂师审查,其中7388条通过EPMOR。共有271条用药医嘱因医嘱修改或停用而未通过药剂师审查,其中105条通过EPMOR。在这105条医嘱中,19条是EPMOR和药剂师都正确识别出的重复医嘱,但相反的重复医嘱被拒绝,51条医嘱因日程安排变更而未通过。
该模拟能够有效地区分和分类医嘱。使用临床驱动算法在EHR中对前瞻性用药医嘱审查过程进行规范化和自动化似乎是可行的。
有必要进一步研究以完善此类算法,以实现价值最大化、提高效率并将安全风险降至最低,为全面自动化系统的实施做好准备。